Mag.pharm. Dr.rer.nat. Theresa BalberPreclinical Imaging Scientist/ Radiopharmacist
Department of Biomedical Imaging and Image-guided Therapy (Division of Nuclear Medicine)
Position: Research Associate (Postdoc)
ORCID: 0000-0002-8154-5680
T +43 1 40400 78300
theresa.balber@meduniwien.ac.at
Keywords
Animal Testing Alternatives; Molecular Imaging; Oncology; Positron-Emission Tomography; Radioactive Tracers; Radiobiology; Radiopharmaceuticals
Research group(s)
- Experimental Nuclear Medicine
Head: Cécile Philippe
Research Area: The research group "Experimental Nuclear Medicine" deals with the development and evaluation of radiotracers in various diseases. In addition, the group focuses on organ axes and pharmacokinetics.
Members: - Joint Medicinal Applied Radiochemistry Facility
Head: Markus Mitterhauser
Research Area: The newly founded Joint Applied Medicinal Radiochemistry Facility of the University of Vienna and the Medical University of Vienna connects researchers from different disciplines of the University of Vienna and the Medical University Vienna ranging from basic science to clinical applications.
Members:
Grants
- The hen´s egg: a model for blood-brain barrier penetration? (2024)
Source of Funding: FWF (Austrian Science Fund), Einzelprojekt
Principal Investigator - Establishment and Evaluation of the In Ovo Xenograft Model for Molecular Imaging in Cancer (2020)
Source of Funding: FFG (Austrian Research Promotion Agency), Forschungspartnerschaften
Principal Investigator
Selected publications
- Benčurová K, Balber T*, Weissenböck V, Kogler L, Friske J, Pichler V, Mitterhauser M, Hacker M, Philippe C, Ozenil M. Preclinical evaluation of the potential PARP-imaging probe [carbonyl-11C]DPQ. EJNMMI Radiopharm Chem. 2025 Jan 10;10(1):1. *authors contributed equally
- Benčurová K, Tran L, Friske J, Bevc K, Helbich TH, Hacker M, Bergmann M, Zeitlinger M, Haug A, Mitterhauser M, Egger G, Balber T. An in vivo tumour organoid model based on the chick embryonic chorioallantoic membrane mimics key characteristics of the patient tissue: a proof-of-concept study. EJNMMI Res. 2024 Sep 27;14(1):86.
- Benčurová K, Friske J, Anderla M, Mayrhofer M, Wanek T, Nics L, Egger G, Helbich TH, Hacker M, Haug A, Mitterhauser M, Balber T. CAM-Xenograft Model Provides Preclinical Evidence for the Applicability of [68Ga]Ga-Pentixafor in CRC Imaging. Cancers (Basel). 2022 Nov 11;14(22):5549.
- Balber T, Tran L, Benčurová K, Raitanen J, Egger G, Mitterhauser M. Experimental Nuclear Medicine Meets Tumor Biology. Pharmaceuticals (Basel). 2022 Feb 14;15(2):227.